• Explore /
  • Poster
  • / Prospective randomized trial of genomic classifier impact on treatment decisions in patients at high risk of recurrence following radical prostatectomy (G-MINOR).

Prospective randomized trial of genomic classifier impact on treatment decisions in patients at high risk of recurrence following radical prostatectomy (G-MINOR).

Abstract Poster

Authors

null

Todd Matthew Morgan

University of Michigan, Ann Arbor, MI

Todd Matthew Morgan , David Christopher Miller , Rodney Dunn , Linsell Susan , Linda Okoth , Anna Johnson , Felix Y Feng , Ghani Khurshid , Elai Davicioni , Marguerite Du Plessis , James E. Montie , Michael L. Cher

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Clinical Trial Registration Number

NCT02783950

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr TPS154)

DOI

10.1200/JCO.2018.36.6_suppl.TPS154

Abstract #

TPS154

Poster Bd #

N17

Abstract Disclosures

Similar Posters

First Author: Stephen J. Freedland

First Author: John L. Gore

First Author: Ashley Ross

First Author: Ashley E. Ross